ERMA Enorama Pharma AB (publ)

0.0508USD0.5160 SEK · STO-4.44%Mkt Cap: 3.79M USDP/E: —

Enorama Pharma AB (publ), a pharmaceutical company, develops, manufactures, and sells tobacco-free white snus in Sweden. It offers its products under the NIC-S brand name. The company was incorporated in 2006 and is base…

Key Statistics

Company
Market Cap3.79M USD
Enterprise Value3.58M USD
Revenue (TTM)142.43K USD
Gross Profit-1.48M USD
Net Income (TTM)-7.40M USD
Revenue/Share0.0019 USD
Last Price0.0508 USD
Fiscal Year EndDec 2025
MR QuarterJun 2026
Employees4
CountrySE
SectorHealthcare
IndustryDrug Manufacturers - Specialty & Generic
ISINSE0008216329
Valuation
P/E (Trailing)—
P/E (Forward)—
PEG—
EV/EBITDA-0.67
EV/Revenue25.15
P/S26.60
P/B-0.76
EPS (TTM)-0.08 USD
EPS (Forward)—
52W Range
0.020812% of range0.2815
52W High0.2815 USD
52W Low0.0208 USD
Profitability
Gross Margin-549.22%
Oper. Margin-3767.24%
EBITDA Margin0.00%
Profit Margin-2743.30%
ROE320.41%
ROA-909.45%
ROIC—
ROCE—
Growth
Revenue Growth-81.50%
Earnings Growth—
Cash Flow & Leverage
Operating CF-5.83M USD
CapEx (TTM)—
FCF Margin-1110.09%
FCF Yield-41.74%
Net Debt-206.51K USD
Net Debt/EBITDA0.04
Net Debt/FCF—
Balance Sheet
Debt/Equity0.00
Current Ratio0.21
Quick Ratio0.12
Book Value/Sh-0.07 USD
Cash/Share0.0028 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.00 USD
Div. Yield0.00%
5Y Avg Yield—
Payout Ratio—
Ex-Div Date—
Pay Date—
Analyst Consensus
Rating—
Target (Mean)—
Target Range—
# Analysts—
Ownership
Shares Out.74.59M
Float60.15M
Insiders91.12%
Institutions1.51%
Technical
SMA 500.0743 (-31.7%)
SMA 2000.0534 (-5.0%)
Beta1.75
S&P 52W Chg12.00%
Avg Vol (30d)162.99K
Avg Vol (10d)139.26K
Technical Indicators
RSI (14)41.0
MACD-0.0577
MACD Signal-0.0244
MACD Hist.-0.0333
BB Upper0.1007 USD
BB Middle0.0746 USD
BB Lower0.0484 USD
BB Width70.10%
ATR (14)0.0181 USD
Vol Ratio (20d)0.36x

About Enorama Pharma (STO: ERMA)

›

Enorama Pharma (STO: ERMA) is listed on Nasdaq Stockholm, where its shares trade in SEK. It belongs to the Drug Manufacturers - Specialty & Generic industry, part of the Healthcare sector, and reports about 4 employees.

The shares were at 0.5160 SEK on 19 November 2026, down 80.5% over 52 weeks. Its 52-week range is 0.2110 SEK to 2.860 SEK: the price is 82.0% below the high and 144.5% above the low.

Its market capitalisation is 38.49M SEK.

Enorama Pharma reports return on equity of 320.4% and revenue down 81.5% year over year.

It holds more cash than debt, a net cash position of 2.10M SEK. Its Piotroski F-score is 1 out of 9, a weak reading of its financial health.